Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 16,598
-478 (-2.80%)
Nov 21, 2025, 3:30 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 212.91 billion as of November 21, 2025. Its market cap has increased by 14.11% in one year.
Market Cap
212.91B
Enterprise Value
213.87B
Revenue
15.33B
Ranking
n/a
PE Ratio
88.66
Stock Price
16,598.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 212.91B, an increase of 63,429.93%. That is a compound annual growth rate of 29.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 212.91B | 20.89% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | 14.04B | 161.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.28T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.07T |
| Zydus Lifesciences | 936.00B |
| Mankind Pharma | 924.37B |
| Aurobindo Pharma | 717.75B |
| Fortis Healthcare | 696.75B |